Femoral deep vein thrombosis (DVT) in cancer patients admitted to specialist palliative care units (SPCUs). Circulatory System
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Admitted to a participating SPCU 2. 18 years or older 3. Able to give fully informed written consent or an available nominated consultee 4. No physical limitations to performing the ultrasound assessment
Exclusion criteria
Exclusion criteria: 1. Patients on other clinical trials will be considered on a case by case basis 2. Patients who are considered by the clinical team likely to die within 5 days 3. Where, in the case of a patient without mental capacity, the nominated consultee is too distressed to be approached regarding the study in the opinion of the clinical team 4. Patients unable to understand English well enough to provide informed consent or comply with study assessments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The prevalence of femoral DVT in cancer patients admitted to specialist palliative care unit (SPCU) measured by Doppler ultrasound | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Incidence of developing a proximal lower limb DVT in patients with and without a diagnosis of cancer during admission to a SPCU 2. Prevalence of clinical symptoms and signs attributable to VTE (proximal lower limb DVT and PE) on admission to a SPCU 3. Incidence of clinical symptoms and signs attributable to VTE (proximal lower limb DVT and PE) during admission to a SPCU 4. Incidence of acute deterioration or sudden death in patients with a known DVT that could be attributed to clinical pulmonary emboli 5. Clinical characteristics associated with the presence or absence of proximal lower limb DVT 6. Association between use of anticoagulation and presence or absence of DVT on admission and during admission to a SPCU 7. Impact of proximal lower limb DVT on length of stay 8. Survival | — |
Countries
England, Northern Ireland, United Kingdom, Wales